100% tevredenheidsgarantie Direct beschikbaar na betaling Zowel online als in PDF Je zit nergens aan vast
logo-home
Multiple Sclerosis Exam/Essay Summary €6,78   In winkelwagen

Samenvatting

Multiple Sclerosis Exam/Essay Summary

 15 keer bekeken  0 keer verkocht
  • Vak
  • Instelling

Summary of notes structured in exam and essay format complete with point, evidence, analysis, and critical thinking. Structured based on marking criteria.

Voorbeeld 3 van de 19  pagina's

  • 10 oktober 2022
  • 19
  • 2022/2023
  • Samenvatting
  • Onbekend
avatar-seller
Contents
Part 1: Summary............................................................................................................................................ 1
Part 2: Background........................................................................................................................................ 3
Part 3: Pathogenesis of MS........................................................................................................................... 6
Part 4: Treatment......................................................................................................................................... 13
Treatment options.................................................................................................................................... 15
Proposed Mechanism of Action................................................................................................................ 15
Disease modifying treatment is neuroprotective.......................................................................................16
Strategies of restoring myelination........................................................................................................... 16
Maximising future success....................................................................................................................... 17
New drugs in trial..................................................................................................................................... 17

Part 1: Summary
Multiple sclerosis (MS) is a chronic inflammatory demyelination disease of the central nervous system
(CNS). In MS, the immune system is thought to attack the myelinated axons in the CNS, impairing the
ability of the CNS to transmit its neuronal signals. This results in a range of symptoms including muscle
weakness, loss of coordination, and blindness. While the exact cause of the disease remains relatively up
for debate, the mechanism by which such demyelination occurs is fairly well understood. Activation of
immune cells drive and trigger MS by targeting the oligodendrocytes and myelin of the CNS. This results in
the pathological hallmark of demyelinated plaques and lesions concomitant with degeneration,
inflammation, and reactive astrocytosis. Interestingly, the location of these lesions is thought to reflect a
specific set of symptoms. While it was traditionally though that these plaques would primarly affect the CNS
white matter, more recent evidence based on pathological and imaging studies propose that demyelination
of the cortex is also present.

There are two underlying views as to how these immune cells are activated. The ‘outside-in’ model
proposes that autoimmunity is generated in the periphery and enters the CNS, while the ‘inside-out’ model
suggests that neurodegeneration is initiated in the CNS, subsequently triggering the immune system as a
secondary phenomenon. Moreover, there are several factors that are thought to increase the risk of
developing MS, such as a history Epstein-Barr virus (EBV).

Pathogenesis

,Main pathological lesions: multiple sclerotic plaques showing demyelination of white and gray matter in
the brain and spinal cord  caused by immune cell infiltration across the BBB that promotes
inflammation, demyelination, gliosis, and neuroaxonal degeneration  leads to disruption of neuronal
signalling
 Consist of well-demarcated hypocellular area
 Characterised by loss of myelin, relative preservation of axons, and formation of astrocytic scars
 In the lesions, myelin, oligodendrocytes and axons are destroyed  axonal dysfunction results from
nerve conduction disorders following demyelination
 Accumulation of demyelinated lesions may lead to neurological features of MS
 During early stages of MS, spontaneous remyelination (where oligodendrocyte progenitor cells re-
ensheath demyelinated axons) will help to restore axonal conduction
o Over time, remyelination fails to compensate for progression of inflammation-drivedn
demyelination
o Consequence axonal damage = permanent, irreversible neurological decline

Pathology
1. Myelin sheaths and oligodendrocytes are destroyed after myeline protien components are
recognised by cells of the immune system
a. Inflammatory reaction includes activation of myelin-specific CD4+ autoreactive T cells and
differentiation into pro-inflammatory Th1-like phenotype + CD8+ T cells, B cells secreting
myelin-directed antibodies
2. Activated lymphocytes recruited from periphery to CNS cross the CSF barrier and BBB
3. Presence of activated immune cells + immunoglobins and cytokines in CSF in patients with MS 
suggests participation of immune system in pathogenesis

, Part 2: Background
 Multiple sclerosis (MS) is a chronic (auto)immune-mediated CNS confined demyelinating disease
affecting 3 million people worldwide and about 130,000 people in the United Kingdom
 Disease onset is usually between 20 and 40 years of age (F:M ratio, 2:1)
 MS is clinically characterized by a relapsing-remitting course usually followed by a progressive
phase
 MS is pathologically heterogeneous – inflammation, demyelination and neurodegeneration (axonal
loss and neuronal damage)
 Spontaneous repair occurs but MS invariably progresses (ambulatory problems in 70-80% patients
at 25 years from onset)
 Society views the Late Stages of MS to be Worse than Death

Characterisation of MS
 Confluent demyelinated areas in white and grey matter of brain and spinal cord  plaques/lesions
 Plaques/lesions indicate loss of myelin sheath and oligodendrocytes
 Ongoing disease = gradual neuroaxonal loss that correlates with patient disability  Brain atrophy
o Accompanied by ventricular enlargement
 Astrocytes form multiple sclerotic glial scars in white matter lesions
 Demyelinated areas in white matter can be partially repaired by remyelination
 Inflammation is more pronounced in acute phases than in chronic phases

Clinical Spectrum

Voordelen van het kopen van samenvattingen bij Stuvia op een rij:

Verzekerd van kwaliteit door reviews

Verzekerd van kwaliteit door reviews

Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!

Snel en makkelijk kopen

Snel en makkelijk kopen

Je betaalt supersnel en eenmalig met iDeal, creditcard of Stuvia-tegoed voor de samenvatting. Zonder lidmaatschap.

Focus op de essentie

Focus op de essentie

Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!

Veelgestelde vragen

Wat krijg ik als ik dit document koop?

Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.

Tevredenheidsgarantie: hoe werkt dat?

Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.

Van wie koop ik deze samenvatting?

Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper denh11323. Stuvia faciliteert de betaling aan de verkoper.

Zit ik meteen vast aan een abonnement?

Nee, je koopt alleen deze samenvatting voor €6,78. Je zit daarna nergens aan vast.

Is Stuvia te vertrouwen?

4,6 sterren op Google & Trustpilot (+1000 reviews)

Afgelopen 30 dagen zijn er 82185 samenvattingen verkocht

Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen

Start met verkopen
€6,78
  • (0)
  Kopen